Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study
Jorge Calderón‐Parra, Andrea Gutiérrez-Villanueva, Gerard Ronda-Roca, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 3, pp. 107095-107095
Open Access | Times Cited: 7

Showing 7 citing articles:

The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance
Drieda Zaçe, Albiana Çekrezi, Christopher M. Jones, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Treatment of chronic COVID‐19 with convalescent/postvaccination plasma in patients with hematologic malignancies
Maike Janssen, Albrecht Leo, Cornelia Wolf, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 4, pp. 618-626
Open Access | Times Cited: 2
Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients
Federico Barone, Andrea Giacomelli, Giacomo Casalini, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 9, pp. 2400-2402
Closed Access | Times Cited: 1
Epidemiological Study in Antiviral Innate Immunity
Xiaoyu Zhao, Yuting Liu, Ruogu Cheng, et al.
Methods in molecular biology (2024), pp. 189-197
Closed Access | Times Cited: 1
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 1
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era
Serena Vita, Emanuela Giombini, Patrizia De Marco, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024043-e2024043
Open Access
Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection
Vincent Soriano, Víctor Moreno‐Torres
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1066-1067
Closed Access
Efficacy of Combination of Antiviral Therapy With Neutralizing Monoclonal Antibodies for Recurrent Persistent SARS‐CoV‐2 Pneumonia in Patients With Lymphoma
Xiaoyan Gai, Xiaoyan Sun, Beibei Liu, et al.
BioMed Research International (2024) Vol. 2024, Iss. 1
Open Access
Page 1

Scroll to top